AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sod...

FDA Recall #D-0159-2017 — Class II — October 24, 2016

Recall #D-0159-2017 Date: October 24, 2016 Classification: Class II Status: Terminated

Product Description

AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-314-10

Reason for Recall

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Recalling Firm

Burel Pharmaceuticals Inc — Richland, MS

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

604 bottles

Distribution

Nationwide

Code Information

LOT # 29421501, EXP 10/17

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated